RE: Going for This week IND submission19 Jun 2025 19:19
Been watching this share since before the re rate, remember someone (maybe here for hemo) suggesting that institutional investors would jump on after the re rate, luckily I kept my powder dry. I can only find estimates of cost per patient ranging between $375,000 and one mil per patient. So genuine question what is the opinion on cost of treatment impacting on wider take up. I read constantly of treatments not be cost effective and NHS refusing to fund, medical insurance not willing to cover costs. Really interested to read opinions.